Products
Online Inquiry
AZD0156
Cat. No.:
OB0225WX-2342
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
AZD0156 is a specific and effective small molecule inhibitor of ATM kinase that possesses intrinsic chemosensitizing and radiosensitizing molecular properties.
Synonym:
1821428-35-6; AZD-0156; 2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-; Azd 0156; AZD 0156 [WHO-DD]; 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one; 8-(6-(3-(dimethylamino)propoxy)pyridin-3-yl)-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-one; 8-(6-(3-(dimethylamino)propoxy)pyridin-3-yl)-3-methyl-1-(oxan-4-yl)imidazo(4,5-c)quinolin-2-one; 8-{6-[3-(dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one; MFCD30470661; 8-(6-(3-(Dimethylamino)propoxy)pyridin-3-yl)-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo(4,5-c)quinolin-2-one; 8-(6-(3-(Dimethylamino)propoxy)pyridin-3-yl)-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one; 8-[6-(3-Dimethylaminopropoxy)pyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[5,4-c]quinolin-2-one
CAS No.:
1821428-35-6
Compound CID:
118502708
Formula:
C26H31N5O3
Formula Weight:
461.56
Specification
Targets&IC50:
ATM: 0.58 nM
Relative Density:
1.242 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
AZD0156 is utilized in oncological studies as a highly potent ATM inhibitor to study the potentiation of PARP inhibitors and the induction of synthetic lethality in DNA-repair-deficient tumors.
Library Information
Target:
ATM/ATR
Receptor:
ATM
Pathways:
DNA damage/DNA repair; Apoptosis; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-31
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
2mM DMSO
DMSO Max Solubility:
1 mg/mL
Water Max Solubility:
<0.1 mg/mL (insoluble)





